TP53 and squamous cell carcinoma: The present study demonstrated that in addition to induction of apoptosis by α-santalol observed in in vitro and in vivo studies [11,12], α-santalol also inhibits human epidermoid carcinoma A431 cell growth and human melanoma UACC-62 cells in vitro through G2/M phase arrest independently on p21 and p53.